Results 241 to 250 of about 1,136,503 (270)
Some of the next articles are maybe not open access.

Effects of anti-IL-23 and anti-IL-17: The hidden side of spondyloarthritis polymorphism?

Joint Bone Spine, 2020
Daniel Wendling   +3 more
openaire   +2 more sources

Resistance Mechanisms to Anti-PD Cancer Immunotherapy

Annual Review of Immunology, 2022
Matthew Vesely, Lieping Chen
exaly  

Anti-IL-23 antibody blockade of IL-23/IL-17 pathway attenuates airway obliteration in rat orthotopic tracheal transplantation.

International Immunopharmacology, 2011
H. Cao   +11 more
semanticscholar   +1 more source

Fluorescent cellulose-based materials for information encryption and anti-counterfeiting

Coordination Chemistry Reviews, 2023
Yongqian Xu, Sg Sun, Hongjuan Li
exaly  

Bacterial Retrons Function In Anti-Phage Defense

Cell, 2020
Azita Leavitt   +2 more
exaly  

Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity

Cell, 2020
Brian C Miller   +2 more
exaly  

Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment

Clinical Rheumatology, 2019
L. Costa   +9 more
semanticscholar   +1 more source

The Expanding Role of Anti-IL-12 and/or Anti-IL-23 Antibodies in the Treatment of Inflammatory Bowel Disease.

Gastroenterology & hepatology
The interleukin (IL)-12/IL-23 pathway is one of many proposed mechanistic pathways of intestinal inflammation. Earlier studies introduced IL-12 as a major cytokine in the pathogenesis of inflammatory bowel disease. However, the discovery of IL-23 drew attention toward this new cytokine.
Amir, Kashani, David A, Schwartz
openaire   +1 more source

Home - About - Disclaimer - Privacy